Find and Pitch Jounalists, Get Your Story Covered

Tags: adipocyte, cell biology, cell culture, oxygen consumption cancer, cell biology, cell cannibalism, developmental biology, entosis cell biology, mouse brain, neuroscience, single-cell RNA sequencing, spatial transcriptomics memory kidney cells

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - 16 days ago Beam’s Base-Editing Sickle Cell Therapy Shows Early Promise, But a Fatality Overshadows Results - about 2 months ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 18 days ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - 19 days ago Biopharma leaders lay out vision for the future of blood cancer treatment - 20 days ago Sanofi advances a drug for a rare, platelet-destroying disease - 21 days ago STAT+: Patient dies in Beam Therapeutics trial of CRISPR sickle cell treatment - about 2 months ago Listen: More tumult at BIO & coercive care for sickle cell patients - 7 months ago STAT+: After sickle-cell screwups, Bluebird Bio’s only option might be a company sale - about 1 year ago In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease - about 1 year ago STAT+: FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show - about 1 year ago
4	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Biopharma leaders lay out vision for the future of blood cancer treatment - 20 days ago Sanofi advances a drug for a rare, platelet-destroying disease - 21 days ago STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease - about 1 year ago STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH - about 1 year ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Biopharma leaders lay out vision for the future of blood cancer treatment - 20 days ago STAT+: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference - 20 days ago Novartis is building a new radioligand plant in China - about 1 year ago
6	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	Biopharma leaders lay out vision for the future of blood cancer treatment - 20 days ago Blood cell counts have unfairly kept Black and Middle Eastern people from clinical trials, study says - 4 months ago
7	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Stem Cell Selection Unneeded for SSc Transplant Therapy? - 25 days ago
8	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The First Crispr Treatment Is Making Its Way to Patients - about 1 month ago The First Crispr Medicine Is Now Approved in the US - about 1 year ago The First Crispr Medicine Just Got Approved - about 1 year ago
9	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	A STAT Investigation: Pain, loss, and coercive care - about 2 months ago STAT Morning Rounds: Six health news stories you need to start your day - about 1 year ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Medicaid coverage of obesity drugs, a death in a sickle cell trial, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more - 11 months ago STAT+: Pricey sickle cell treatments raise daunting new challenges for Medicaid programs - 11 months ago STAT+: Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish - about 1 year ago STAT+: Pharmalittle: Bluebird’s sickle-cell screwups may prompt a sale; drugmakers raised prices on widely used meds without new clinical evidence - about 1 year ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - about 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - about 1 year ago STAT+: Pharmalittle: FDA flags safety concerns with CRISPR-based sickle cell treatment; FDA warns about eye drop infection risk - about 1 year ago

Journalists covering sickle cell